Global Anti-Neprilysin Antibody Market Growth (Status and Outlook) 2023-2029

March 2023 | 86 pages | ID: G7005D9FAD09EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Neprilysin is a neutral endopeptidase and its inhibition increases bioavailability of natriuretic peptides, bradykinin, and substance P, resulting in natriuretic, vasodilatatory, and anti-proliferative effects.

LPI (LP Information)' newest research report, the “Anti-Neprilysin Antibody Industry Forecast” looks at past sales and reviews total world Anti-Neprilysin Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Neprilysin Antibody sales for 2023 through 2029. With Anti-Neprilysin Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Neprilysin Antibody industry.

This Insight Report provides a comprehensive analysis of the global Anti-Neprilysin Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Neprilysin Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Neprilysin Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Neprilysin Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Neprilysin Antibody.

The global Anti-Neprilysin Antibody market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Anti-Neprilysin Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Anti-Neprilysin Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Anti-Neprilysin Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Anti-Neprilysin Antibody players cover Bioprojet SCR, Novartis International AG, Pharmaleads SA, Theravance Biopharma Inc., Cipla Limited and Oceanic Pharmachem Pvt. Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Neprilysin Antibody market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Sacubitril
• TD-0714
• STR-324
• PL-265
• LHW-090

Segmentation by application

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bioprojet SCR
• Novartis International AG
• Pharmaleads SA
• Theravance Biopharma Inc.
• Cipla Limited
• Oceanic Pharmachem Pvt. Ltd

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-Neprilysin Antibody Market Size 2018-2029
  2.1.2 Anti-Neprilysin Antibody Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Anti-Neprilysin Antibody Segment by Type
  2.2.1 Sacubitril
  2.2.2 TD-0714
  2.2.3 STR-324
  2.2.4 PL-265
  2.2.5 LHW-090
2.3 Anti-Neprilysin Antibody Market Size by Type
  2.3.1 Anti-Neprilysin Antibody Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Anti-Neprilysin Antibody Market Size Market Share by Type (2018-2023)
2.4 Anti-Neprilysin Antibody Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Anti-Neprilysin Antibody Market Size by Application
  2.5.1 Anti-Neprilysin Antibody Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Anti-Neprilysin Antibody Market Size Market Share by Application (2018-2023)

3 ANTI-NEPRILYSIN ANTIBODY MARKET SIZE BY PLAYER

3.1 Anti-Neprilysin Antibody Market Size Market Share by Players
  3.1.1 Global Anti-Neprilysin Antibody Revenue by Players (2018-2023)
  3.1.2 Global Anti-Neprilysin Antibody Revenue Market Share by Players (2018-2023)
3.2 Global Anti-Neprilysin Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTI-NEPRILYSIN ANTIBODY BY REGIONS

4.1 Anti-Neprilysin Antibody Market Size by Regions (2018-2023)
4.2 Americas Anti-Neprilysin Antibody Market Size Growth (2018-2023)
4.3 APAC Anti-Neprilysin Antibody Market Size Growth (2018-2023)
4.4 Europe Anti-Neprilysin Antibody Market Size Growth (2018-2023)
4.5 Middle East & Africa Anti-Neprilysin Antibody Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Anti-Neprilysin Antibody Market Size by Country (2018-2023)
5.2 Americas Anti-Neprilysin Antibody Market Size by Type (2018-2023)
5.3 Americas Anti-Neprilysin Antibody Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-Neprilysin Antibody Market Size by Region (2018-2023)
6.2 APAC Anti-Neprilysin Antibody Market Size by Type (2018-2023)
6.3 APAC Anti-Neprilysin Antibody Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Anti-Neprilysin Antibody by Country (2018-2023)
7.2 Europe Anti-Neprilysin Antibody Market Size by Type (2018-2023)
7.3 Europe Anti-Neprilysin Antibody Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-Neprilysin Antibody by Region (2018-2023)
8.2 Middle East & Africa Anti-Neprilysin Antibody Market Size by Type (2018-2023)
8.3 Middle East & Africa Anti-Neprilysin Antibody Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTI-NEPRILYSIN ANTIBODY MARKET FORECAST

10.1 Global Anti-Neprilysin Antibody Forecast by Regions (2024-2029)
  10.1.1 Global Anti-Neprilysin Antibody Forecast by Regions (2024-2029)
  10.1.2 Americas Anti-Neprilysin Antibody Forecast
  10.1.3 APAC Anti-Neprilysin Antibody Forecast
  10.1.4 Europe Anti-Neprilysin Antibody Forecast
  10.1.5 Middle East & Africa Anti-Neprilysin Antibody Forecast
10.2 Americas Anti-Neprilysin Antibody Forecast by Country (2024-2029)
  10.2.1 United States Anti-Neprilysin Antibody Market Forecast
  10.2.2 Canada Anti-Neprilysin Antibody Market Forecast
  10.2.3 Mexico Anti-Neprilysin Antibody Market Forecast
  10.2.4 Brazil Anti-Neprilysin Antibody Market Forecast
10.3 APAC Anti-Neprilysin Antibody Forecast by Region (2024-2029)
  10.3.1 China Anti-Neprilysin Antibody Market Forecast
  10.3.2 Japan Anti-Neprilysin Antibody Market Forecast
  10.3.3 Korea Anti-Neprilysin Antibody Market Forecast
  10.3.4 Southeast Asia Anti-Neprilysin Antibody Market Forecast
  10.3.5 India Anti-Neprilysin Antibody Market Forecast
  10.3.6 Australia Anti-Neprilysin Antibody Market Forecast
10.4 Europe Anti-Neprilysin Antibody Forecast by Country (2024-2029)
  10.4.1 Germany Anti-Neprilysin Antibody Market Forecast
  10.4.2 France Anti-Neprilysin Antibody Market Forecast
  10.4.3 UK Anti-Neprilysin Antibody Market Forecast
  10.4.4 Italy Anti-Neprilysin Antibody Market Forecast
  10.4.5 Russia Anti-Neprilysin Antibody Market Forecast
10.5 Middle East & Africa Anti-Neprilysin Antibody Forecast by Region (2024-2029)
  10.5.1 Egypt Anti-Neprilysin Antibody Market Forecast
  10.5.2 South Africa Anti-Neprilysin Antibody Market Forecast
  10.5.3 Israel Anti-Neprilysin Antibody Market Forecast
  10.5.4 Turkey Anti-Neprilysin Antibody Market Forecast
  10.5.5 GCC Countries Anti-Neprilysin Antibody Market Forecast
10.6 Global Anti-Neprilysin Antibody Forecast by Type (2024-2029)
10.7 Global Anti-Neprilysin Antibody Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Bioprojet SCR
  11.1.1 Bioprojet SCR Company Information
  11.1.2 Bioprojet SCR Anti-Neprilysin Antibody Product Offered
  11.1.3 Bioprojet SCR Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Bioprojet SCR Main Business Overview
  11.1.5 Bioprojet SCR Latest Developments
11.2 Novartis International AG
  11.2.1 Novartis International AG Company Information
  11.2.2 Novartis International AG Anti-Neprilysin Antibody Product Offered
  11.2.3 Novartis International AG Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Novartis International AG Main Business Overview
  11.2.5 Novartis International AG Latest Developments
11.3 Pharmaleads SA
  11.3.1 Pharmaleads SA Company Information
  11.3.2 Pharmaleads SA Anti-Neprilysin Antibody Product Offered
  11.3.3 Pharmaleads SA Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Pharmaleads SA Main Business Overview
  11.3.5 Pharmaleads SA Latest Developments
11.4 Theravance Biopharma Inc.
  11.4.1 Theravance Biopharma Inc. Company Information
  11.4.2 Theravance Biopharma Inc. Anti-Neprilysin Antibody Product Offered
  11.4.3 Theravance Biopharma Inc. Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Theravance Biopharma Inc. Main Business Overview
  11.4.5 Theravance Biopharma Inc. Latest Developments
11.5 Cipla Limited
  11.5.1 Cipla Limited Company Information
  11.5.2 Cipla Limited Anti-Neprilysin Antibody Product Offered
  11.5.3 Cipla Limited Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Cipla Limited Main Business Overview
  11.5.5 Cipla Limited Latest Developments
11.6 Oceanic Pharmachem Pvt. Ltd
  11.6.1 Oceanic Pharmachem Pvt. Ltd Company Information
  11.6.2 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Product Offered
  11.6.3 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Oceanic Pharmachem Pvt. Ltd Main Business Overview
  11.6.5 Oceanic Pharmachem Pvt. Ltd Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Anti-Neprilysin Antibody Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Sacubitril
Table 3. Major Players of TD-0714
Table 4. Major Players of STR-324
Table 5. Major Players of PL-265
Table 6. Major Players of LHW-090
Table 7. Anti-Neprilysin Antibody Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Anti-Neprilysin Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Anti-Neprilysin Antibody Market Size Market Share by Type (2018-2023)
Table 10. Anti-Neprilysin Antibody Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Anti-Neprilysin Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Anti-Neprilysin Antibody Market Size Market Share by Application (2018-2023)
Table 13. Global Anti-Neprilysin Antibody Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Anti-Neprilysin Antibody Revenue Market Share by Player (2018-2023)
Table 15. Anti-Neprilysin Antibody Key Players Head office and Products Offered
Table 16. Anti-Neprilysin Antibody Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Anti-Neprilysin Antibody Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Anti-Neprilysin Antibody Market Size Market Share by Regions (2018-2023)
Table 21. Global Anti-Neprilysin Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Anti-Neprilysin Antibody Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Anti-Neprilysin Antibody Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Anti-Neprilysin Antibody Market Size Market Share by Country (2018-2023)
Table 25. Americas Anti-Neprilysin Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Anti-Neprilysin Antibody Market Size Market Share by Type (2018-2023)
Table 27. Americas Anti-Neprilysin Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Anti-Neprilysin Antibody Market Size Market Share by Application (2018-2023)
Table 29. APAC Anti-Neprilysin Antibody Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Anti-Neprilysin Antibody Market Size Market Share by Region (2018-2023)
Table 31. APAC Anti-Neprilysin Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Anti-Neprilysin Antibody Market Size Market Share by Type (2018-2023)
Table 33. APAC Anti-Neprilysin Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Anti-Neprilysin Antibody Market Size Market Share by Application (2018-2023)
Table 35. Europe Anti-Neprilysin Antibody Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Anti-Neprilysin Antibody Market Size Market Share by Country (2018-2023)
Table 37. Europe Anti-Neprilysin Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Anti-Neprilysin Antibody Market Size Market Share by Type (2018-2023)
Table 39. Europe Anti-Neprilysin Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Anti-Neprilysin Antibody Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Anti-Neprilysin Antibody Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Anti-Neprilysin Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Anti-Neprilysin Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Anti-Neprilysin Antibody
Table 48. Key Market Challenges & Risks of Anti-Neprilysin Antibody
Table 49. Key Industry Trends of Anti-Neprilysin Antibody
Table 50. Global Anti-Neprilysin Antibody Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Anti-Neprilysin Antibody Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Anti-Neprilysin Antibody Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Anti-Neprilysin Antibody Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Bioprojet SCR Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 55. Bioprojet SCR Anti-Neprilysin Antibody Product Offered
Table 56. Bioprojet SCR Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Bioprojet SCR Main Business
Table 58. Bioprojet SCR Latest Developments
Table 59. Novartis International AG Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 60. Novartis International AG Anti-Neprilysin Antibody Product Offered
Table 61. Novartis International AG Main Business
Table 62. Novartis International AG Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Novartis International AG Latest Developments
Table 64. Pharmaleads SA Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 65. Pharmaleads SA Anti-Neprilysin Antibody Product Offered
Table 66. Pharmaleads SA Main Business
Table 67. Pharmaleads SA Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Pharmaleads SA Latest Developments
Table 69. Theravance Biopharma Inc. Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 70. Theravance Biopharma Inc. Anti-Neprilysin Antibody Product Offered
Table 71. Theravance Biopharma Inc. Main Business
Table 72. Theravance Biopharma Inc. Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Theravance Biopharma Inc. Latest Developments
Table 74. Cipla Limited Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 75. Cipla Limited Anti-Neprilysin Antibody Product Offered
Table 76. Cipla Limited Main Business
Table 77. Cipla Limited Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Cipla Limited Latest Developments
Table 79. Oceanic Pharmachem Pvt. Ltd Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 80. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Product Offered
Table 81. Oceanic Pharmachem Pvt. Ltd Main Business
Table 82. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Oceanic Pharmachem Pvt. Ltd Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Anti-Neprilysin Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-Neprilysin Antibody Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Anti-Neprilysin Antibody Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Anti-Neprilysin Antibody Sales Market Share by Country/Region (2022)
Figure 8. Anti-Neprilysin Antibody Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Anti-Neprilysin Antibody Market Size Market Share by Type in 2022
Figure 10. Anti-Neprilysin Antibody in Hospital Pharmacies
Figure 11. Global Anti-Neprilysin Antibody Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Anti-Neprilysin Antibody in Retail Pharmacies
Figure 13. Global Anti-Neprilysin Antibody Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Anti-Neprilysin Antibody in Online Pharmacies
Figure 15. Global Anti-Neprilysin Antibody Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Anti-Neprilysin Antibody Market Size Market Share by Application in 2022
Figure 17. Global Anti-Neprilysin Antibody Revenue Market Share by Player in 2022
Figure 18. Global Anti-Neprilysin Antibody Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Anti-Neprilysin Antibody Market Size 2018-2023 ($ Millions)
Figure 20. APAC Anti-Neprilysin Antibody Market Size 2018-2023 ($ Millions)
Figure 21. Europe Anti-Neprilysin Antibody Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Anti-Neprilysin Antibody Market Size 2018-2023 ($ Millions)
Figure 23. Americas Anti-Neprilysin Antibody Value Market Share by Country in 2022
Figure 24. United States Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Anti-Neprilysin Antibody Market Size Market Share by Region in 2022
Figure 29. APAC Anti-Neprilysin Antibody Market Size Market Share by Type in 2022
Figure 30. APAC Anti-Neprilysin Antibody Market Size Market Share by Application in 2022
Figure 31. China Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Anti-Neprilysin Antibody Market Size Market Share by Country in 2022
Figure 38. Europe Anti-Neprilysin Antibody Market Size Market Share by Type (2018-2023)
Figure 39. Europe Anti-Neprilysin Antibody Market Size Market Share by Application (2018-2023)
Figure 40. Germany Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Anti-Neprilysin Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 54. APAC Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 55. Europe Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 57. United States Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 58. Canada Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 61. China Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 62. Japan Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 63. Korea Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 65. India Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 66. Australia Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 67. Germany Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 68. France Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 69. UK Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 70. Italy Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 71. Russia Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 72. Spain Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 75. Israel Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Anti-Neprilysin Antibody Market Size 2024-2029 ($ Millions)
Figure 78. Global Anti-Neprilysin Antibody Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Anti-Neprilysin Antibody Market Size Market Share Forecast by Application (2024-2029)